SMi Reports: Karl Hess from OnDigitalHealth Consulting to present at Disruptive Technologies in Pharma conference in London on the 20th and 21st January.
For those interested in attending, an early bird saving of £200 for bookings made by 31st October is available www.disruptivetech-pharma.com/prcom5
As the event draws closer, SMi had a discussion with Chairman Karl Hess, Managing Director, OnDigitalHealth Consulting regarding his views and expectations on the conference and on the current developments within the industry.
Karl Hess is a digital health and population health management platform ecosystem builder, leader, investor and evangelist, as well as a subject matter expert on the topics of successful digital health business models, commercialization, investment and technologies, having interacted directly with hundreds of digital health companies over the last 10 years. Karl is currently Founding Managing Director of OnDigitalHealth Consulting, LLC, a specialized strategy consulting firm which he founded to serve the burgeoning and rapidly diversifying digital health industry.
Snapshot of Karls Interview:
What is your background in disruptive technologies and how do you contribute to driving healthcare disruption with your everyday work?
Well, with over 25 years in the healthcare and life sciences industries, the majority of which were focused on innovation and value creation, I’ve had the opportunity to do a lot of different things. I’ve worked with and for hundreds of companies in the space, helping to develop and commercialise solutions across software, hardware, SaaS / PaaS, cloud, healthcare information technology (HIT), digital health, population health management (PHM), interoperability, artificial intelligence (AI), machine learning (ML), natural language processing (NLP), wearables, remote patient monitoring (RPM), telemedicine, clinical decision support (CDS), Internet of Things (IoT), analytics, pharmaceuticals
What do you consider as drivers of digital transformation and why do you think there is a need for such changes in the global healthcare landscape?
Several factors come to mind, including the rapid pace of technological innovation, which has greatly impacted the availability of data – coming from a myriad number of sources today – and the handling, management, storage of and access to this data…”
Featured speakers include:
Joseph Dalton, Global Lead Digital Health Solutions and Medical Outcomes, Novartis
Umair Aslam, e-Health Lead, MSD
Dr Andrew Bate, Senior Director, Analytics Team Lead, Pfizer
Bhushan Bonde, Head of IT – Early Solution Innovation Development, UCB
Vladimir Anisimov, Principal Data Scientist, Amgen
Jessica Shull, European Lead, Digital Therapeutics Alliance
For the full interview and event details with the complete speaker line-up, the brochure is available to download on the website www.disruptivetech-pharma.com/prcom5
Disruptive Technologies in Pharma
20th 21st January 2020
London, UK
Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.
Let’s block ads! (Why?)
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…